We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Health Effects Following Use of Lead Free Ammunition Used With HK416

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01477645
First Posted: November 22, 2011
Last Update Posted: October 16, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Norwegian Defence Research Establishment
Information provided by (Responsible Party):
Svein Grahnstedt, Oslo University Hospital
November 18, 2011
November 22, 2011
October 16, 2013
November 2011
January 2012   (Final data collection date for primary outcome measure)
Forced Expiratory Volume (FEV1) [ Time Frame: Before, Immediately after, and 24 hrs after exposure ]
Not Provided
Complete list of historical versions of study NCT01477645 on ClinicalTrials.gov Archive Site
Inflammation markers [ Time Frame: Before and 24 hrs after esposure ]
Not Provided
Subjective Symptoms [ Time Frame: During exposure, and during the 24 hrs after exposure ]
Not Provided
 
Health Effects Following Use of Lead Free Ammunition Used With HK416
In Norwegian: Helseffekter av Stoff Som Avgis Ved Skyting Med HK416
The purpose of this study is to determine whether use of lead free ammunitions cause more respiratory problems than use of lead containing ammunitions.
Not Provided
Observational
Observational Model: Ecologic or Community
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Sputum and serum
Non-Probability Sample
Voluntary army soldiers
  • Lung Function Tests
  • Markers of Inflammation
Not Provided
  • Leaded ammunition
  • Non-leaded ammunition
  • Modified non-leaded ammunition
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
55
March 2012
January 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • healthy volunteers

Exclusion Criteria:

  • active respiratory disease
Sexes Eligible for Study: Male
20 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01477645
2011/1335
No
Not Provided
Not Provided
Svein Grahnstedt, Oslo University Hospital
Oslo University Hospital
Norwegian Defence Research Establishment
Study Director: Kjetil Longva, PhD Norwegian Defence Reasearch Establishment
Principal Investigator: Anne-Katrine Borander, MD Oslo University Hospital
Principal Investigator: Øyvind Albert Voie, PhD Norwegian Research Defence Establishment
Study Director: Johny S Kongerud, MD PhD Oslo University Hospital
Principal Investigator: Liv Ingunn Bjoner Sikkeland, PhD Oslo University Hospital
Oslo University Hospital
October 2013